Telemus Capital, LLC Biomarin Pharmaceutical Inc Transaction History

Telemus Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 28, 2021	SELL	$72.61 - $90.2 $971,376 - $1.21 Million	-13,378 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$71.87 - $131.03 $793,947 - $1.45 Million	11,047 Added 473.92%	13,378 $1.06 Million
Q2 2020 Jul 17, 2020	BUY	$79.55 - $124.22 $185,431 - $289,556	2,331 New	2,331 $294,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Telemus Capital, LLC with notifications on news.